Neuroprosthetics Market

The neuroprosthetics market consists of implantable and wearable devices that interface with the nervous system to restore lost sensory, motor, or cognitive functions. The primary customers are individuals suffering from neurological conditions such as Parkinson’s disease, epilepsy, spinal cord injuries, and hearing or vision loss. Key growth drivers for the market include the rising incidence of these neurological disorders, significant technological advancements like AI integration and miniaturization, and increasing healthcare investments globally.

CAGR

15.5%

Compound Annual Growth Rate

Current Value

$19.5B

Estimated 2026

Projected Value

$61.8B

By 2034